LexisNexis® Legal Newsroom
Potential Changes to "Orphan Drug" Exclusions Under the Patient Protection and Affordable Health Care Act

In July 2003, my father was diagnosed with renal cell carcinoma (kidney cancer). The disease would end his life in less than a year. Shortly after he died, news broke regarding a drug that was showing promise for advanced stage kidney cancer patients. The drug could extend life for an average of three...